ACE2 enhance viral infection or viral infection aggravate the underlying diseases
ACE2 plays a critical role in SARS-CoV-2 infection to cause COVID-19 and SARS-CoV-2 spike protein binds to ACE2 and probably functionally inhibits ACE2 to aggravate the underlying diseases of COVID-19. The important factors that affect the severity and fatality of COVID-19 include patients' underlying diseases and ages. Therefore, particular care to the patients with underlying diseases is needed during the treatment of COVID-19 patients.
Teng, Shaolei and Tang, Qiyi, "ACE2 enhance viral infection or viral infection aggravate the underlying diseases" (2020). College of Medicine Faculty Publications. 253.